You are here

Article info

Article menu

Download PDFPDF

Editorial
Metabolomics for rheumatic diseases: has the time come?
Free

Authors

  • Luca Semerano Inserm UMR 1125, Bobigny, France Sorbonne Paris Cité—Université Paris 13, Bobigny, France Assistance Publique—Hôpitaux de Paris (AP-HP) Groupe hospitalier Avicenne—Jean Verdier—René Muret, Service de Rhumatologie, Bobigny, France PubMed articlesGoogle scholar articles
  • Paul-Henri Roméo LRTS/DSV/CEA, UMR967, Inserm, CEA, Paris-Diderot, Paris-Sud, Fontenay-aux-Roses, Cedex, France PubMed articlesGoogle scholar articles
  • Marie-Christophe Boissier Inserm UMR 1125, Bobigny, France Sorbonne Paris Cité—Université Paris 13, Bobigny, France Assistance Publique—Hôpitaux de Paris (AP-HP) Groupe hospitalier Avicenne—Jean Verdier—René Muret, Service de Rhumatologie, Bobigny, France PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Marie-Christophe Boissier, Inserm UMR 1125, 74 rue Marcel Cachin, Bobigny 93000, France; marie-chistophe.boissier{at}avc.aphp.fr
View Full Text

Citation

Semerano L, Roméo P, Boissier M
Metabolomics for rheumatic diseases: has the time come?
Annals of the Rheumatic Diseases 2015;74:1325-1326.

Publication history

  • Received November 5, 2014
  • Revised December 22, 2014
  • Accepted January 6, 2015
  • First published January 21, 2015.
Online issue publication 
November 02, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions